Smart MRI boosts brain cancer zapping therapy

NCT ID NCT05086497

Recruiting now Disease control Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests a more precise way to place electrodes on the scalp of glioblastoma patients receiving tumor treating fields (TTFields) therapy. Using advanced MRI that maps cancer spread, researchers aim to deliver stronger electrical doses to the tumor. The goal is to slow cancer growth and improve survival. About 155 adults who have had surgery and radiation will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GBM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GBM GLIOMA GLIOBLASTOMA MULTIFORME TUMOR, BRAIN

Contacts and locations

Locations

Abramson Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Penn Medicine, University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.